患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Recruiting

• Multi-Centre, Retrospective, Open Label Study, to Validate ML-PrediCare by Patients With Melanoma Under 1st and 2nd Lines of Immunotherapy
• Melanoma;Melanoma
• Israel
• 2015-10-19

• Recruiting

• Clinical study of Apatinib Mesylate Tablets in the Second-line treatment of Advanced Squamous Cell Lung Cancer
• Squamous Cell Lung Cancer
• China
• 2016-08-19

• Recruiting

• Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy
• Bladder Cancer;Ureter Cancer;Transitional Cell Carcinoma;Bladder Cancer;Ureter Cancer;Transitional Cell Carcinoma;Bladder Cancer;Ureter Cancer;Transitional Cell Carcinoma;Bladder Cancer;Ureter Cancer;Transitional Cell Carcinoma
• Korea, Republic of
• 2016-08-13

• Recruiting

• Clinical study of TCM 'Liangxue Shugan fang' in the treatment of postoperative estrogen receptor-positive breast cancer patients
• Estrogen receptor-positive breast cancer
• China
• 2016-08-03

• Not Recruiting

• SBRT combined with DC-CIK immunotherapy in advanced none-small cell lung cancer after failure of second-line therapy
• lung cancer
• China
• 2016-07-06

• Not Recruiting

• The prospective, open, multi-center clinical study of Apatinib(Aitan) in non-first-line treating patient with recurrent/metastatic head and neck squamous cell carcinoma
• recurrent / metastatic head and neck squamous cell carcinoma
• China
• 2016-06-30

• Authorised

• A Phase III Study to Evaluate Chemotherapy With or Without Pembrolizumab as First Line Treatment for Triple Negative Breast Cancer
• Triple-Negative Breast Cancer MedDRA version: 20.0 Level: PT Classification code 10075566 Term: Triple negative breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
• Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, Hungary, Ireland, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
• 2016-06-08

• Authorised

• A Phase III Study to Evaluate Chemotherapy With or Without Pembrolizumab as First Line Treatment for Triple Negative Breast Cancer
• Triple-Negative Breast Cancer MedDRA version: 20.0 Level: PT Classification code 10075566 Term: Triple negative breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
• Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, Hungary, Ireland, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
• 2016-05-23

• Recruiting

• A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
• Carcinoma, Non-Small-Cell Lung
• Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hong Kong, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Singapore, Spain, Taiwan, Turkey, United Kingdom, United States
• 2017-01-20

• Recruiting

• Human Recombinant Endostatin Injection Durative Transfusion Combined With Chemotherapy in The First-line Treatment of Advanced Lung Squamous Carcinoma
• Squamous Cell Lung Cancer
• China
• 2017-01-16

• Not Recruiting

• First-line randomized, open, controlled clinical trial of EP regimen with sequential apatinib in patients with extensive stage small cell lung cancer
• extensive stage small cell lung cancer
• China
• 2017-01-09

• Recruiting

• Genomic Study of Dipeptidyl Peptidase-4 (DPP-4) and Glucagon-Like Peptide 1 Receptor (GLP1R) in Chinese and it's Apply in Antidiabetes
• Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus
• China
• 2017-01-04

• Recruiting

• Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer
• Pancreatic Cancer
• Australia, Austria, Belgium, Canada, France, Germany, Ireland, Italy, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom, United States
• 2016-09-30

• Not Recruiting

• Dual therapy with asomeprazole and amoxicillin in the first-line eradication of Helicobacter pylori
• Helicobacter pylori infection
• China
• 2017-12-22

• Authorised

• Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy
• Metastatic colorectal cancer MedDRA version: 20.0 Level: PT Classification code 10052358 Term: Colorectal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
• Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Turkey, Ukraine, United Kingdom
• 2017-12-22

• Authorised

• Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy
• Metastatic colorectal cancer MedDRA version: 20.0 Level: PT Classification code 10052358 Term: Colorectal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
• Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Turkey, Ukraine, United Kingdom
• 2017-12-19

• Recruiting

• A Non-randomized, Open-label, Prospective, Multicenter Study of Apatinib Mesylate Tablet as Second-line and Later Therapy in Patients With Extensive Stage Small Cell Lung Cancer
• Small Cell Lung Cancer
• China
• 2017-12-15

• Not Recruiting

• The effect of Metformin combine with FOLFOX + Bevacizumab as the first-line therapy in metastatic colorectal cancer, a randomized, open, prospective clinical study (BeFoLMe study)
• Colorectal Cancer;C18.9,C20
• China
• 2017-12-15

• Recruiting

• Clinical study of Apatinib combined with docetaxel as second-line treatment in advanced gastric cancer
• gastric cancer
• China
• 2017-12-11

• Recruiting

• The Combination Chemotherapy of SIRIOX as First-Line Chemotherapy for Pancreatic Cancer
• Carcinoma, Pancreatic Ductal
• China
• 2017-11-28